Evidence map›Paper›PMID 38605416›Full record

ArticleAlzheimer's research & therapy2024

Biophysical models applied to dementia patients reveal links between geographical origin, gender, disease duration, and loss of neural inhibition.

Sebastian Moguilner, Rubén Herzog, Yonatan Sanz Perl, Vicente Medel, Josefina Cruzat, Carlos Coronel, Morten Kringelbach, Gustavo Deco, Agustín Ibáñez, Enzo Tagliazucchi

Abstract read
In one paragraph

Article in Alzheimer's research & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Creative experiences and brain clocks.Nature communications · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sebastian MoguilnerLatin American Brain Health (BrainLat), Universidad Adolfo Ibáñez, Av. Diag. Las Torres 2640, Santiago Región Metropolitana, Peñalolén, 7941169, Chile.
Rubén HerzogLatin American Brain Health (BrainLat), Universidad Adolfo Ibáñez, Av. Diag. Las Torres 2640, Santiago Región Metropolitana, Peñalolén, 7941169, Chile.
Yonatan Sanz PerlCognitive Neuroscience Center (CNC), Universidad de San Andrés, Vito Dumas 284, B1644BID, Buenos Aires, VIC, Argentina.
Vicente MedelLatin American Brain Health (BrainLat), Universidad Adolfo Ibáñez, Av. Diag. Las Torres 2640, Santiago Región Metropolitana, Peñalolén, 7941169, Chile.
Josefina CruzatLatin American Brain Health (BrainLat), Universidad Adolfo Ibáñez, Av. Diag. Las Torres 2640, Santiago Región Metropolitana, Peñalolén, 7941169, Chile.
Carlos CoronelLatin American Brain Health (BrainLat), Universidad Adolfo Ibáñez, Av. Diag. Las Torres 2640, Santiago Región Metropolitana, Peñalolén, 7941169, Chile.
Morten KringelbachCentre for Eudaimonia and Human Flourishing, Linacre College, University of Oxford, St.Cross Rd, Oxford, OX1 3JA, UK.
Gustavo DecoCenter for Brain and Cognition, Computational Neuroscience Group, Universitat Pompeu Fabra, Plaça de La Mercè, 10-12, Barcelona, 08002, Spain.
Agustín IbáñezLatin American Brain Health (BrainLat), Universidad Adolfo Ibáñez, Av. Diag. Las Torres 2640, Santiago Región Metropolitana, Peñalolén, 7941169, Chile. agustin.ibanez@gbhi.org.
Enzo TagliazucchiLatin American Brain Health (BrainLat), Universidad Adolfo Ibáñez, Av. Diag. Las Torres 2640, Santiago Región Metropolitana, Peñalolén, 7941169, Chile. tagliazucchi.enzo@googlemail.com.

Funding

US-South American Initiative for Genetic-Neural-Behavioral Interactions in Human Neurodegenerative ResearchR01AG057234 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Claudia Duran-Aniotz, Agustin M. Ibanez · 2019 to 2026
$6.1M
Alzheimer's Association GBHI ALZ UK-21-721776Alzheimer's Association SG-20-725707-ReDLatNIA NIH HHS R01 AG057234
6 · The paper itself

Abstract

backgroundThe hypothesis of decreased neural inhibition in dementia has been sparsely studied in functional magnetic resonance imaging (fMRI) data across patients with different dementia subtypes, and the role of social and demographic heterogeneities on this hypothesis remains to be addressed.

methodsWe inferred regional inhibition by fitting a biophysical whole-brain model (dynamic mean field model with realistic inter-areal connectivity) to fMRI data from 414 participants, including patients with Alzheimer's disease, behavioral variant frontotemporal dementia, and controls. We then investigated the effect of disease condition, and demographic and clinical variables on the local inhibitory feedback, a variable related to the maintenance of balanced neural excitation/inhibition.

resultsDecreased local inhibitory feedback was inferred from the biophysical modeling results in dementia patients, specific to brain areas presenting neurodegeneration. This loss of local inhibition correlated positively with years with disease, and showed differences regarding the gender and geographical origin of the patients. The model correctly reproduced known disease-related changes in functional connectivity.

conclusionsResults suggest a critical link between abnormal neural and circuit-level excitability levels, the loss of grey matter observed in dementia, and the reorganization of functional connectivity, while highlighting the sensitivity of the underlying biophysical mechanism to demographic and clinical heterogeneities in the patient population.

Indexed as

Alzheimer DiseaseFrontotemporal DementiaBrainGray MatterHumansMagnetic Resonance ImagingNeural InhibitionBiophysical modelingDementiaGenderHeterogeneityHyperexcitabilityNeurodegenerationVariability

Identifiers

PMID38605416
PMCPMC11008050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.